Bleichroeder LP Finch Therapeutics Group, Inc. Transaction History

Bleichroeder LP

  • $296 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Jun 03, 2021
BUY
$15.54 - $21.32 $12.6 Million - $17.3 Million
810,416 New
810,416 $13.1 Million

About Finch Therapeutics Group, Inc.

FNCH Quotes by TradingView
  • Ticker FNCH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,688,400
  • Market Cap $575M
  • Description
  • Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...
More about FNCH
Track This Portfolio

Track Bleichroeder LP Portfolio

Follow Bleichroeder LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

News

Stay updated on Bleichroeder LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email